Gotu Kola (Centella asiatica) vs Phenibut

Mechanism

Pentacyclic triterpenes — asiaticoside, madecassoside, asiatic acid, and madecassic acid — provide neuroprotection through multiple mechanisms: inhibition of acetylcholinesterase activity and enhancement of cholinergic transmission; reduction of phospholipase A2 (PLA2) activity to attenuate neuroinflammation; protection against beta-amyloid aggregation and tau hyperphosphorylation; and upregulation of BDNF to promote neuronal growth and synaptic plasticity. Asiaticoside enhances collagen synthesis and wound healing, while asiatic acid activates the MAPK/ERK pathway to promote neurite outgrowth.

Standard Dosing

500-1000 mg/day of standardized extract (35-45% triterpenes) or 750-1500 mg/day of whole herb extract

Timing

Morning or split morning/afternoon. With or without food. Acute mood effects (alertness, reduced anger) noted within 1 hour of dosing.

Cycle Duration

Ongoing; traditional use suggests no cycling required. Clinical trials run 2-6 months.

Side Effects

• GI discomfort
• Drowsiness
• Headache
• Skin irritation (topical use)
• Hepatotoxicity (rare, with prolonged high-dose use)

Contraindications

• Pregnancy (traditionally contraindicated; may have emmenagogue effects)
• Hepatic disease (rare hepatotoxicity reported)
• Scheduled surgery (may affect wound healing dynamics)

Best Stacking Partners

Mechanism

Beta-phenyl derivative of GABA that crosses the blood-brain barrier (unlike GABA itself) due to the addition of a phenyl ring. Acts as a full agonist at GABA-B receptors with 30-68x lower affinity than baclofen, requiring correspondingly higher doses. Also binds to and blocks alpha-2-delta subunit-containing voltage-dependent calcium channels (VDCCs), making it a gabapentinoid similar to gabapentin and pregabalin. At low concentrations, mildly increases dopamine levels in the brain, providing stimulatory and nootropic effects alongside anxiolysis. Weak agonist activity at GABA-A receptors at higher doses.

Standard Dosing

250-750 mg as needed, maximum 1-2 times per week (for educational context — carries significant dependence risk)

Timing

On an empty stomach (food significantly reduces absorption). Onset 2-4 hours. Effects last 4-8 hours with residual effects up to 24 hours. Half-life approximately 5.3 hours.

Cycle Duration

STRICTLY intermittent use only — maximum 1-2 times per week. NEVER use daily for more than 1 week. Tolerance develops within days, leading to dose escalation and dependence.

Side Effects

• Drowsiness/sedation
• Dizziness
• Nausea
• Tolerance (develops rapidly)
• Physical dependence (can occur within 1-2 weeks of daily use)
• Withdrawal syndrome (anxiety, insomnia, tremor, psychosis, hallucinations, seizures)
• Hangover effect
• Motor incoordination at high doses

Contraindications

• History of substance use disorder
• Epilepsy
• Renal impairment (primarily renally excreted)
• Concurrent use of any CNS depressant
• Pregnancy and lactation
• Severe hepatic impairment
• History of benzodiazepine or alcohol dependence

Best Stacking Partners